Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Preliminary research suggests that naloxone (Narcan), a short-acting opiate antagonist, could be provided by prescription or distribution to heroin users to reduce the likelihood of fatality from overdose. We conducted a random postal survey of 1.100 prescription-authorized health care providers in New York City to determine willingness to prescribe naloxone to patients at risk of an opiate overdose. Among 363 nurse practitioners, physicians, and physician assistants responding, 33,4% would consider prescribing naloxone, and 29.4% were unsure. This preliminary study suggests that a substantial number of New York City health care providers would prescribe naloxone for opiate overdose prevention.
Strang J. Take-home naloxone: the next steps. Addiction. 1999;94:207.CrossRef
Strang J, Darke S, Hall S, Farrell M, Ali R, Heroin overdose: the case for take-home naloxone—editorial. BMJ. 1996;312:1435–1436.PubMed
Sporer KA. Acute heroin overdose. Ann Intern Med. 1999;130:584–590.PubMed
Seal KH, Hammond JP, Ciccarone D, Downing M, Thawley R, Edlin B. Providing naloxone to IDUs can save lives. Paper presented at: Fourth National Harm Reduction Conference; December 1, 2002; Seattle, WA.
Bigg D, Maxwell S. Enabling people to stay alive: an effective opiate overdose prevention program. Paper presented at: Fourth National Harm Reduction Conference; December, 1, 2002;Seattle, WA.
Campana S. Overdose mortality and naloxone distribution in Italy, Paper presented at: Prevention Heroin Overdose: Pragmatic Approaches; January 13–14, 2000; Seattle, WA.
Seal K, Downing M, Kral AH, et al. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay area. J Urban Health. 2003;80:290–301.
Lenton SR, Hargreaves KM. Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose? Med J Aust. 2000;173:260–263.PubMed
Burris S, Norland J, Edlin B. Legal aspects of providing naloxone to heroin users in the United States. Int J Drug Policy. 2001;12:237–248.CrossRef
Vilke GM, Buchanan J, Dunford JV, Chan TC. Are heroin overdose deaths related to patient release after prehospital treatment with naloxone? Prebosp Emerg Care. 1999;3:183–186.
- Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City
Journal of Urban Health
Volume 80, Issue 2 , pp 288-290
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links